Bought More NRI.TO the last couple of days under $4.20. I'm not concerned I think results will look very good overall. Also keep in Mind we got look at pennsaid 2% sales through HZNP they were up roughly 10% sequentially, so the drug seems alive and well. Whether they manufactured the same or more sometimes there can be a lag, but If they report earnings in the .20's at the very least I expect the stock to get a significant pop from current levels keep in mind they haven't expanded internationally with this drug yet. All is just my opinion, and I could always be wrong though.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.